Why Asia-Pacific attracts 60% of all ongoing and planned hepatology trials globally
There are more than 1,300 clinical trials in hepatology, either ongoing or planned, in Asia-Pacific. This represents about 60% of…
Read More…
Focus:
-
![virtual covid-19 clinical trials]()
Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials
After announcing a partnership to assess the safety of potential Covid-19 drugs, TRHC and Regence...
Read More...
-
![regeneron covid-19]()
A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment
Having grown into one of the biggest companies in the biotech sphere since its inception...
Read More...
-
![fibrogen covid-19]()
FibroGen: The company attempting to treat pneumonia in Covid-19 patients
FibroGen recently announced enrolment of patients in a clinical study of its antibody drug pamrevlumab...
Read More...
-
![covid-19 moderna vaccine]()
Moderna timeline: How the biotech firm has moved alongside pharma giants in Covid-19 vaccine race
Alongside Pfizer, Merck, Johnson & Johnson and AstraZeneca, Moderna was recently selected as a Covid-19...
Read More...
-
![covid-19 chloroquine trials]()
‘Social responsibility’ may be reason chloroquine trials are continuing despite setbacks
Hydroxychloroquine, a chloroquine drug, has temporarily been dropped from global WHO trials for Covid-19 treatments...
Read More...
-
![]()
IRT: A competitive advantage to accelerate clinical trials during a global pandemic and beyond
Interactive Response Technology (IRT) can serve many different functions in clinical research, from patient randomisation to making data-driven calculations for…
Read More…
-
![uk covid-19 clinical trials]()
UK position in global clinical trials sector could receive boost after Covid-19, says industry boss
The RECOVERY and ACCORD studies taking place across the UK right now are some of...
Read More...
-
![oxford university covid-19]()
How the University of Oxford is leading the Covid-19 fight on multiple fronts
As well as developing its own Covid-19 vaccine, the University of Oxford is leading multiple...
Read More...
-
![combined covid-19 treatments]()
Firms may find it ‘difficult’ to co-market combined Covid-19 drugs, says analyst
Currently, one of the most prominent Covid-19 treatments being trialled is a combined approach involving...
Read More...
